z-logo
open-access-imgOpen Access
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice
Author(s) -
David M. Alvarado,
Juhee Son,
Larissa B. Thackray,
María Florencia Gómez Castro,
Sarada C. Prasad,
Xueyang Cui,
Naomi Sonnek,
Michael Diamond,
Siyuan Ding,
Matthew A. Ciorba
Publication year - 2021
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izab274
Subject(s) - covid-19 , medicine , inflammatory bowel disease , disease , immunology , virology , infectious disease (medical specialty) , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom